letrozole (Femara)

DRUG4 trials

Sponsors

Rijnstate Hospital, University of Alabama at Birmingham, Danish Breast Cancer Cooperative Group, Sanofi

Conditions

Breast CancerBreast NeoplasmCancer of the BreastHypogonadotrophic HypogonadismObesityOperable Breast Neoplasms

Phase 1

Study of XL147 (SAR245408) or XL765 (SAR245409) in Combination With Letrozole in Subjects With Breast Cancer

CompletedNCT01082068

SanofiBreast Cancer

Start: 2010-06-30End: 2013-04-30Updated: 2016-06-03

Phase 2

Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer

CompletedNCT00530868

University of Alabama at BirminghamBreast Cancer, Breast Neoplasm, Cancer of the Breast

Start: 2007-10-08End: 2022-03-31Updated: 2022-10-21

Phase 3

Short-term Effects of Aromatase Inhibition in Obese Men

CompletedNCT00138710

Rijnstate HospitalHypogonadotrophic Hypogonadism, Obesity

Start: 2005-08-31End: 2010-01-31Target: 50Updated: 2010-10-22

Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer

TerminatedNCT00908531

Danish Breast Cancer Cooperative GroupOperable Breast Neoplasms

Start: 2009-05-31End: 2013-12-01Updated: 2019-04-29

Related Papers

Tumour-infiltrating lymphocytes and response to neoadjuvant letrozole in patients with early oestrogen receptor-positive breast cancer: analysis from a nationwide phase II DBCG trial

Breast Cancer Research2020-05-1441 citations